• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Incredible Footage May Be First Evidence Wild Wolves Have Figured Out How To Use Tools
  • Raccoons In US Cities Are Evolving To Become More Pet-Like
  • How Does CERN’s Antimatter Factory Work? We Visited To Find Out
  • Elusive Gingko-Toothed Beaked Whale Seen Alive For First Time Ever
  • Candidate Gravitational Wave Detection Hints At First-Of-Its-Kind Incredibly Small Object
  • People Are Just Learning What A Baby Eel Is Called
  • First-Ever Look At Neanderthal Nasal Cavity Shatters Expectations
  • Traces Of Photosynthetic Lifeforms 1 Billion Years Older Than Previous Record-Holder Discovered
  • This 12,000-Year-Old Artwork Shows An “Extraordinary” Moment In History And Human Creativity
  • World’s First Critically Endangered Penguin Directly Competes With Fishing Boats For Food
  • Parasitic Ant Queens Use Chemical Warfare To Incite Revolutions Against Reigning Queens
  • Data From Mars Lets ESA Predict 3I/ATLAS’s Path 10 Times More Precisely
  • A Massive Gold Deposit Worth $192 Billion Has Been Discovered As Prices Stay Sky High For 2025
  • See It For Yourself: Your Chance To See Interstellar Comet 3I/ATLAS Livestreamed This Week
  • A Woman Born Missing Most Of Her Brain Just Celebrated Her 20th Birthday. What Does That Mean?
  • When And Where Interstellar Objects Like 3I/ATLAS Are Most Likely To Hit Earth
  • Person In The US Infected With A Form Of Bird Flu Never Seen In Humans Before
  • Carl Sagan Left A Heartfelt Message For The First People To Set Foot On Mars
  • People Are Just Learning About A Key Feature Of The Statue Of Liberty That Everyone Forgets
  • Lupus Linked To Virus That Over 95 Percent Of Us Carry, First Radio Detection Received From Interstellar Object 3I/ATLAS, And Much More This Week
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version